Through direct inhibition of VDAC1 conductance, metformin and specific VDAC1 inhibitors (VBIT-4) and antibodies were reported to restore the impaired generation of ATP and glucose-stimulated insulin secretion in T2D pancreatic islets. This evidence concerns the gene INS and type 2 diabetes mellitus.